Karin Arkenbout

428 total citations
15 papers, 104 citations indexed

About

Karin Arkenbout is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karin Arkenbout has authored 15 papers receiving a total of 104 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 11 papers in Cardiology and Cardiovascular Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karin Arkenbout's work include Coronary Interventions and Diagnostics (13 papers), Cardiac Valve Diseases and Treatments (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Karin Arkenbout is often cited by papers focused on Coronary Interventions and Diagnostics (13 papers), Cardiac Valve Diseases and Treatments (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Karin Arkenbout collaborates with scholars based in Netherlands, United Kingdom and Latvia. Karin Arkenbout's co-authors include Jan G.P. Tijssen, Robbert J. de Winter, Arnoud W.J. van ‘t Hof, Peter den Heijer, Harry Suryapranata, Andrés Íñiguez, Philippe Müller, Ian Menown, Pier Woudstra and Deborah N. Kalkman and has published in prestigious journals such as Journal of the American College of Cardiology, Circulation Research and BMJ Open.

In The Last Decade

Karin Arkenbout

13 papers receiving 103 citations

Peers

Countries citing papers authored by Karin Arkenbout

Since Specialization

Citations

This map shows the geographic impact of Karin Arkenbout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Arkenbout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Arkenbout more than expected).

Fields of papers citing papers by Karin Arkenbout

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Arkenbout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Arkenbout. The network helps show where Karin Arkenbout may publish in the future.

Co-authorship network of co-authors of Karin Arkenbout

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Arkenbout. A scholar is included among the top collaborators of Karin Arkenbout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Arkenbout. Karin Arkenbout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Impact of lesion preparation and stent optimisation on lesion-oriented events in PCI with drug-eluting stents: 5-year results from the AIDA trial 2025 ·Netherlands Heart Journal ·(unknown), Maik J. Grundeken, (unknown), Robin P. Kraak, Deborah N. Kalkman, René J. van der Schaaf, Sjoerd H. Hofma, Karin Arkenbout, (unknown), Karel T. Koch, Yoshinobu Onuma, Patrick W. Serruys, Jan G.P. Tijssen, Robbert J. de Winter, Joanna J. Wykrzykowska, R. Tijssen	0
2	Timing of invasive strategy in patients with non-ST segment elevation acute myocardial infarction: A nationwide retrospective cohort analysis 2025 ·Netherlands Heart Journal ·Cyril Camaro, Marijke Timmermans, (unknown), (unknown), (unknown), Dennis van Veghel, Karin Arkenbout, Peter W. Danse	0
3	An iterative approach to developing a multifaceted implementation strategy for a complex eHealth intervention within clinical practice 2023 ·BMC Health Services Research ·(unknown), Rosalie van der Vaart, Linda D. Breeman, Karin Arkenbout, Mike Keesman, Roderik A. Kraaijenhagen, Andrea W.M. Evers, Wilma J.M. Scholte op Reimer, Veronica R. Janssen	5
4	Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction and residual nonflow limiting lesions: rationale and design of the PECTUS-obs study 2021 ·BMJ Open ·Jan‐Quinten Mol, Anouar Belkacemi, (unknown), Martijn Meuwissen, А. В. Протопопов, Peep Laanmets, Oleg Krestyaninov, Robert Dennert, Rohit M. Oemrawsingh, Jan‐Peter van Kuijk, Karin Arkenbout, Dirk J. van der Heijden, Saman Rasoul, Erik Lipšic, Steven Teerenstra, Cyril Camaro, Peter Damman, (unknown), Robert‐Jan van Geuns, Niels van Royen	10
5	Final five‐year results of the REMEDEE Registry: Real‐world experience with the dual‐therapy COMBO stent 2020 ·Catheterization and Cardiovascular Interventions ·(unknown), Jaya Chandrasekhar, Deborah N. Kalkman, Pier Woudstra, Ian Menown, Harry Suryapranata, Peter den Heijer, Andrés Íñiguez, Arnoud W.J. van ‘t Hof, Andrejs Ērglis, Karin Arkenbout, Philippe Müller, Karel T. Koch, Jan G.P. Tijssen, Marcel A.M. Beijk, Robbert J. de Winter	6
6	500.02 Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study. 2019 ·JACC: Cardiovascular Interventions ·R. Tijssen, René J. van der Schaaf, Robin P. Kraak, Maarten A. Vink, Sjoerd H. Hofma, Karin Arkenbout, (unknown), (unknown), Patrick W. Serruys, Yoshinobu Onuma, Marcel A.M. Beijk, Karel T. Koch, Jan Baan, Marije M. Vis, Jan J. Piek, Jan G.P. Tijssen, José P.S. Henriques, Robbert J. de Winter, Joanna J. Wykrzykowska	1
7	Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial 2019 ·EuroIntervention ·(unknown), R. Tijssen, Sjoerd H. Hofma, René J. van der Schaaf, Karin Arkenbout, Robin P. Kraak, (unknown), Jan J. Piek, Robbert J. de Winter, Jan G.P. Tijssen, José P.S. Henriques, Joanna J. Wykrzykowska, (unknown), (unknown), (unknown), (unknown), (unknown)	7
8	Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry 2019 ·Cardiovascular revascularization medicine ·(unknown), Deborah N. Kalkman, Pier Woudstra, Ian Menown, Harry Suryapranata, Peter den Heijer, Andrés Íñiguez, Arnoud W.J. van ‘t Hof, Andrejs Ērglis, Karin Arkenbout, Philippe Müller, Karel T. Koch, Jan G.P. Tijssen, Marcel A.M. Beijk, Robbert J. de Winter	2
9	Three‐year clinical outcomes after dual‐therapy COMBO stent placement: Insights from the REMEDEE registry 2018 ·Catheterization and Cardiovascular Interventions ·Deborah N. Kalkman, (unknown), Pier Woudstra, Ian Menown, Harry Suryapranata, Peter den Heijer, Andrés Íñiguez, Arnoud W.J. van ‘t Hof, Andrejs Ērglis, Karin Arkenbout, Philippe Müller, Karel T. Koch, Jan G.P. Tijssen, Marcel A.M. Beijk, Robbert J. de Winter	7
10	Abstract 477: Nuclear Receptor Nur77 Modulates Cardiac Function via Neuropeptide Y and Neuropeptide Y Receptor 1 Signalling 2017 ·Circulation Research ·Lejla Medzikovic, (unknown), Antonius Baartscheer, Esther E. Creemers, Carol Ann Remme, Karin Arkenbout, (unknown), Vivian de Waard	1
11	Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome 2017 ·Catheterization and Cardiovascular Interventions ·Deborah N. Kalkman, Pier Woudstra, (unknown), Ian Menown, Peter den Heijer, Harry Suryapranata, Andrés Íñiguez, Karin Arkenbout, Arnoud W.J. van ‘t Hof, Philippe Müller, Andrejs Ērglis, Jan G.P. Tijssen, Marcel A.M. Beijk, Robbert J. de Winter	10
12	Two-year clinical outcomes of patients treated with the dual-therapy stent in a 1000 patient all-comers registry 2017 ·Open Heart ·Deborah N. Kalkman, Pier Woudstra, Ian Menown, Peter den Heijer, Arnoud W.J. van ‘t Hof, Andrejs Ērglis, Harry Suryapranata, Karin Arkenbout, Andrés Íñiguez, Philippe Müller, Jan G.P. Tijssen, Marcel A.M. Beijk, Robbert J. de Winter	9
13	1-Year Results of the REMEDEE Registry 2016 ·JACC: Cardiovascular Interventions ·Pier Woudstra, Deborah N. Kalkman, Peter den Heijer, Ian Menown, Andrejs Ērglis, Harry Suryapranata, Karin Arkenbout, Andrés Íñiguez, Arnoud W.J. van ‘t Hof, Philippe Müller, Jan G.P. Tijssen, Robbert J. de Winter	27
14	One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent 2016 ·International Journal of Cardiology ·Deborah N. Kalkman, Pier Woudstra, Peter den Heijer, Ian Menown, Andrejs Ērglis, Harry Suryapranata, Karin Arkenbout, Andrés Íñiguez, Arnoud W.J. van ‘t Hof, Philippe Müller, Jan G.P. Tijssen, Robbert J. de Winter	18
15	TCT-63 One Year Results Of The REMEDEE Registry: Clinical Outcomes After Deployment Of The Abluminal Sirolimus Coated Bio-Engineerd Stent In A Multicenter, Prospective Post Market Registry 2015 ·Journal of the American College of Cardiology ·Robbert J. de Winter, Peter den Heijer, Ian Menown, Andrejs Ērglis, Harry Suryapranata, Karin Arkenbout, Andrés Íñiguez, Arnoud W.J. van ‘t Hof, Philippe Müller, Pier Woudstra, Deborah N. Kalkman, Jan G.P. Tijssen	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact